Publications

regional journals & presentations

Publications

  1. Amorim G, Jaworski J, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Turner M, Andrade BB, Velez Edwards DR, Santos AR, Rolla VC, Sterling TR, Haas DW; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil network. Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort. medRxiv [Preprint]. 2023 Sep 1:2023.08.30.23294860. doi: 10.1101/2023.08.30.23294860. PMID: 37693472; PMCID: PMC10491388.
  2. Barreto-Duarte B, Villalva-Serra K, Miguez-Pinto JP, Araújo-Pereira M, Campos VMS, Rosier G, Nogueira BMF, Queiroz ATL, Rolla VC, Cordeiro-Santos M, Kritski AL, Martinez L, Rebeiro PF, Sterling TR, Rodrigues MM, Andrade BB. Retreatment and Anti-tuberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study. Open Forum Infect Dis. 2024 Jul 18;11(8):ofae416. doi: 10.1093/ofid/ofae416. PMID: 39100532; PMCID: PMC11297487.
  3. Villalva-Serra K, Barreto-Duarte B, Miguez-Pinto JP, Queiroz ATL, Rodrigues MM, Rebeiro PF, Amorim G, Cordeiro-Santos M, Sterling TR, Araújo-Pereira M, Andrade BB. Impact of Xpert MTB/RIF implementation in tuberculosis case detection and control in Brazil: a nationwide intervention time-series analysis (2011-2022). Lancet Reg Health Am. 2024 Jun 5;36:100804. doi: 10.1016/j.lana.2024.100804. PMID: 38912329; PMCID: PMC11192787.
  4. Xavier MS, Araujo-Pereira M, de Oliveira QM, Sant’Anna FM, Ridolfi FM, de Andrade AMS, Figueiredo MC, Sterling TR, Gordhan BG, Kana BD, Andrade BB, Rolla VC, Gomes-Silva A. The effect of previous SARS-CoV-2 infection on systemic immune responses in individuals with tuberculosis. Front Immunol. 2024 Jun 27;15:1357360. doi: 10.3389/fimmu.2024.1357360. PMID: 38994357; PMCID: PMC11236595.
  5. Arriaga MB, Amorim G, Figueiredo MC, Staats C, Kritski AL, Cordeiro-Santos M, Rolla VC, Andrade BB, Sterling TR; RePORT-Brazil consortia. Effect of Smoking on Longitudinal Interferon-ϒ Release Assay Results among Close Contacts of People with Pulmonary Tuberculosis. J Infect Dis. 2024 May 31:jiae285. doi: 10.1093/infdis/jiae285. Epub ahead of print. PMID: 38820119.
  6. Rodrigues, M.M.S., Barreto-Duarte, B., Vinhaes, C.L. et al.Machine learning algorithms using national registry data to predict loss to follow-up during tuberculosis treatment. BMC Public Health 24, 1385 (2024). https://doi.org/10.1186/s12889-024-18815-0
  7. Mendelsohn SC, Andrade BB, Mbandi SK, Andrade AMS, Muwanga VM, Figueiredo MC, Erasmus M, Rolla VC, Thami PK, Cordeiro-Santos M, Penn-Nicholson A, Kritski AL, Hatherill M, Sterling TR, Scriba TJ; RePORT-South Africa and RePORT-Brazil Consortia. Transcriptomic signatures of progression to TB disease among close contacts in Brazil. J Infect Dis. 2024 May 6:jiae237. doi: 10.1093/infdis/jiae237. Epub ahead of print. PMID: 38709708.
  8. Vinhaes CL, Fukutani ER, Santana GC, Arriaga MB, Barreto-Duarte B, Araújo-Pereira M, Maggitti-Bezerril M, Andrade AMS, Figueiredo MC, Milne GL, Rolla VC, Kristki AL, Cordeiro-Santos M, Sterling TR, Andrade BB, Queiroz ATL; RePORT Brazil Consortium. An integrative multi-omics approach to characterize interactions between tuberculosis and diabetes mellitus. iScience. 2024 Feb 5;27(3):109135. doi: 10.1016/j.isci.2024.109135. PMID: 38380250; PMCID: PMC10877940.
  9. Ridolfi F, Amorim G, Peetluk LS, Haas DW, Staats C, Araújo-Pereira M, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Andrade BB, Rolla VC, Sterling TR; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil consortium. Prediction models for adverse drug reactions during tuberculosis treatment in Brazil. J Infect Dis. 2024 Jan 23:jiae025. doi: 10.1093/infdis/jiae025. Epub ahead of print. PMID: 38262629.
  10. Enane LA, Duda SN, Chanyachukul T, Bolton-Moore C, Navuluri N, Messou E, Mbonze N, McDade LR, Figueiredo MC, Ross J, Evans D, Diero L, Akpata R, Zotova N, Freeman A, Pierre MF, Rupasinghe D, Ballif M, Byakwaga H, de Castro N, Tabala M, Sterling TR, Sohn AH, Fenner L, Wools-Kaloustian K, Poda A, Yotebieng M, Huebner R, Marcy O; International epidemiology Databases to Evaluate AIDS. The Tuberculosis Sentinel Research Network (TB-SRN) of the International epidemiology Databases to Evaluate AIDS (IeDEA): protocol for a prospective cohort study in Africa, Southeast Asia and Latin America. BMJ Open. 2024 Jan 9;14(1):e079138. doi: 10.1136/bmjopen-2023-079138. PMID: 38195167.
  11. Mariana Araújo-Pereira, María B Arriaga, Anna Cristina C Carvalho, Renata Spener-Gomes, Carolina A S Schmaltz, Betânia M F Nogueira, Marina C Figueiredo, Megan M Turner, Marcelo Cordeiro-Santos, Valeria C Rolla, Timothy R Sterling, Bruno B Andrade, Afrânio L Kritski, for the RePORT-Brazil Consortium, Isoniazid monoresistance and anti-tuberculosis treatment outcome in persons with pulmonary tuberculosis in Brazil, Open Forum Infectious Diseases, 2024;
  12. Garcia LS, Costa AG, Araújo-Pereira M, Spener-Gomes R, Aguiar AF, Souza AB, Lima LOA, Benjamin A, Rocha MS, Moreira ASR, Silva J, Santos SRN, Lourenço MC, Figueiredo MC, Turner MM, Kritski AL, Rolla VC, Sterling TR, Andrade BB, Cordeiro-Santos M; RePORT Brazil Consortium. The Xpert® MTB/RIF cycle threshold value predicts M. tuberculosis transmission to close contacts in a Brazilian prospective multicenter cohort. Clin Infect Dis. 2024 Jan 3:ciad794. doi: 10.1093/cid/ciad794. Epub ahead of print. PMID: 38170196.
  13. Rocha EF, Vinhaes CL, Araújo-Pereira M, Mota TF, Gupte AN, Kumar NP, Arriaga MB, Sterling TR, Babu S, Gaikwad S, Karyakarte R, Mave V, Kulkarni V, Paradkar M, Viswanathan V, Kornfeld H, Gupta A, Andrade BB, Queiroz ATL; RePORT Brazil; RePORT India Consortia. The sound of silent RNA in tuberculosis and the lncRNA role on infection. iScience. 2023 Dec 8;27(1):108662. doi: 10.1016/j.isci.2023.108662. PMID: 38205253; PMCID: PMC10777062.
  14. Queiroz, A.T.L., Vinhaes, C.L., Fukutani, E.R. et al.A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction. Sci Rep 13, 7769 (2023). https://doi.org/10.1038/s41598-023-34847-9
  15. Araújo-Pereira M, Nogueira BMF, Spener-Gomes R, Carvalho ACC, Sant’Anna FM, Figueiredo MC, Turner MM, Kritski AL, Cordeiro-Santos M, Rolla VC, Sterling TR, Andrade BB; RePORT-Brazil Consortium. Anemia and anti-tuberculosis treatment outcome in persons with pulmonary tuberculosis: A multi-center prospective cohort study. J Infect Public Health. 2023 Apr 18;16(6):974-980. doi: 10.1016/j.jiph.2023.04.009. PMID: 37121049.
  16. Ridolfi F, Peetluk L, Amorim G, Turner M, Figueiredo M, Cordeiro-Santos M, Cavalcante S, Kritski A, Durovni B, Andrade B, Sterling TR, Rolla V; Regional Prospective Observational Research in Tuberculosis (RePORT)–Brazil Consortium. Tuberculosis Treatment Outcomes in Brazil: Different Predictors for Each Type of Unsuccessful Outcome. Clin Infect Dis. 2023 Feb 8;76(3):e930-e937. doi: 10.1093/cid/ciac541. PMID: 35788646; PMCID: PMC10169436.
  17. Nogueira BMF, Krishnan S, Barreto-Duarte B, Araújo-Pereira M, Queiroz ATL, Ellner JJ, Salgame P, Scriba TJ, Sterling TR, Gupta A, Andrade BB. Diagnostic biomarkers for active tuberculosis: progress and challenges. EMBO Mol Med. 2022 Oct 31:e14088. doi: 10.15252/emmm.202114088. Epub ahead of print. PMID: 36314872.
  18. Villalva-Serra K, Barreto-Duarte B, Nunes VM, Menezes RC, Rodrigues MMS, Queiroz ATL, Arriaga MB, Cordeiro-Santos M, Kritski AL, Sterling TR, Araújo-Pereira M, Andrade BB. Tuberculosis treatment outcomes of diabetic and non-diabetic TB/HIV co-infected patients: A nationwide observational study in Brazil. Front Med (Lausanne). 2022 Sep 16;9:972145. doi: 10.3389/fmed.2022.972145. PMID: 36186793; PMCID: PMC9523014.
  19. Sobral L, Arriaga MB, Souza AB, Araújo-Pereira M, Barreto-Duarte B, Sales C, Rocha MS, Benjamin A, Moreira ASR, Oliveira JG, Carvalho AC, Spener-Gomes R, Figueiredo MC, Cavalcante S, Durovni B, Lapa-e-Silva JR, Kritski AL, Rolla VC, Sterling TR, Cordeiro-Santos M, Andrade BB. Determinants of losses in the tuberculosis infection cascade of care among children and adolescent contacts of pulmonary tuberculosis cases: A Brazilian multi-centre longitudinal study. The Lancet Regional Health – Americas, 2022, 100358, ISSN 2667-193X, https://doi.org/10.1016/j.lana.2022.100358.
  20. Arriaga MB, Karim F, Queiroz ATL, Araújo-Pereira M, Barreto-Duarte B, Sales C, Moosa MS, Mazibuko M, Milne GL, Maruri F, Serezani CH, Koethe JR, Figueiredo MC, Kritski AL, Cordeiro-Santos M, Rolla VC, Sterling TR, Leslie A, Andrade BB. Effect of Dysglycemia on Urinary Lipid Mediator Profiles in Persons With Pulmonary Tuberculosis. Front Immunol. 2022 Jul 8;13:919802. doi: 10.3389/fimmu.2022.919802. PMID: 35874781; PMCID: PMC9304990.
  21. Wada PY, Costa AG, Araújo-Pereira M, Barreto-Duarte B, Souza AB, Rocha MS, Figueiredo MC, Turner MM, Rolla VC, Kritski AL, Cordeiro-Santos M, Andrade BB, Sterling TR, Rebeiro PF; Regional Prospective Observational Research in Tuberculosis (RePORT) Brazil Consortium. Possible Sex Difference in Latent Tuberculosis Infection Risk among Close Tuberculosis Contacts. Int J Infect Dis. 2022 Jul 14:S1201-9712(22)00426-X. doi: 10.1016/j.ijid.2022.07.031. Epub ahead of print. PMID: 35843494.
  22. Queiroz ATL, Araújo-Pereira M, Barreto-Duarte B, Gomes-Silva A, Costa AG, Andrade AMS, Miguez-Pinto JP, Spener-Gomes R, Souza AB, Benjamin A, Sant’Anna F, Figueiredo MC, Mave V, Salgame P, Ellner JJ, Sterling TR, Cordeiro-Dos-Santos M, Andrade BB, Rolla VC. Immunologic Biomarkers in Peripheral Blood of Persons With Tuberculosis and Advanced HIV. Front Immunol. 2022 Jun 10;13:890003. doi: 10.3389/fimmu.2022.890003. PMID: 35757685; PMCID: PMC9226490.
  23. Arriaga MB, Araújo-Pereira M, Barreto-Duarte B, Sales C, Miguez-Pinto JP, Nogueira EB, Nogueira BMF, Rocha MS, Souza AB, Benjamin A, de Oliveira JG, Moreira ASR, Queiroz ATL, Rodrigues MMS, Spener-Gomes R, Figueiredo MC, Durovni B, Cavalcante S, Lapa-E-Silva JR, Kristki AL, Cordeiro-Santos M, Sterling TR, Rolla VC, Andrade BB; RePORT-Brazil consortium. Prevalence and Clinical Profiling of Dysglycemia and HIV Infection in Persons With Pulmonary Tuberculosis in Brazil. Front Med (Lausanne). 2022 Jan 21;8:804173. doi: 10.3389/fmed.2021.804173. PMID: 35127760; PMCID: PMC8814308.
  24. Costa AG, Carvalho BKS, Araújo-Pereira M, Ibiapina HNS, Spener-Gomes R, Souza AB, Gomes-Silva A, Andrade AMS, Silva EC, Arriaga MB, Benjamin A, Rocha MS, Moreira ASR, Oliveira JG, Figueiredo MC, Turner MM, Durovni B, Cavalcante S, Kritski AL, Rolla VC, Sterling TR, Andrade BB, Cordeiro-Santos M; RePORT-Brazil Consortium. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil. Microbiol Spectr. 2021 Dec 1:e0116321. doi: 10.1128/Spectrum.01163-21. Epub ahead of print. PMID: 34851140.
  25. Arriaga MB, Araújo-Pereira M, Barreto-Duarte B, Nogueira B, Freire MVCNS, Queiroz ATL, Rodrigues MMS, Rocha MS, Souza AB, Spener-Gomes R, Carvalho ACC, Figueiredo MC, Turner MM, Durovni B, Lapa-E-Silva JR, Kritski AL, Cavalcante S, Rolla VC, Cordeiro-Santos M, Sterling TR, Andrade BB; RePORT Brazil consortium. The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study. J Infect Dis. 2021 Oct 15:jiab427. doi: 10.1093/infdis/jiab427. Epub ahead of print. PMID: 34651642.
  26. Souza AB, Arriaga MB, Amorim G, Araújo-Pereira M, Nogueira BMF, Queiroz ATL, Figueiredo MC, Rocha MS, Benjamin A, Moreira ASR, Oliveira JG, Rolla V, Durovni B, Lapa E Silva JR, Kritski AL, Cavalcante S, Sterling T, Andrade BB, Cordeiro-Santos M; RePORT Brazil consortium. Determinants of losses in the latent tuberculosis infection cascade of care in Brazil. BMJ Glob Health. 2021 Sep;6(9):e005969. doi: 10.1136/bmjgh-2021-005969. PMID: 34518204.
  27. Barreto-Duarte B, Araújo-Pereira M, Nogueira BMF, Sobral L, Rodrigues MMS, Queiroz ATL, Rocha MS, Nascimento V, Souza AB, Cordeiro-Santos M, Kritski AL, Sterling TR, Arriaga MB, Andrade BB. Tuberculosis Burden and Determinants of Treatment Outcomes According to Age in Brazil: A Nationwide Study of 896,314 Cases Reported Between 2010 and 2019. Front Med (Lausanne). 2021 Jul 27;8:706689. doi: 10.3389/fmed.2021.706689. PMID: 34386510; PMCID: PMC8354381.
  28. Carvalho ACC, Amorim G, Melo MGM, Silveira AKA, Vargas PHL, Moreira ASR, Rocha MS, Souza AB, Arriaga MB, Araújo-Pereira M, Figueiredo MC, Durovni B, Lapa-E-Silva JR, Cavalcante S, Rolla VC, Sterling TR, Cordeiro-Santos M, Andrade BB, Silva EC, Kritski AL; RePORT Brazil consortium. Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study. Front Immunol. 2021 Jul 2;12:661934. doi: 10.3389/fimmu.2021.661934. PMID: 34276654; PMCID: PMC8284392.
  29. Peetluk LS, Rebeiro PF, Ridolfi FM, Andrade BB, Cordeiro-Santos M, Kritski A, Durovni B, Calvacante S, Figueiredo MC, Haas DW, Liu D, Rolla VC, Sterling TR; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil network. A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes. Clin Infect Dis. 2021 Jul 2:ciab598. doi: 10.1093/cid/ciab598. Epub ahead of print. PMID: 34214166.
  30. Arriaga MB, Rocha MS, Nogueira B, Nascimento V, Araújo-Pereira M, Souza AB, Andrade AMS, Costa AG, Gomes-Silva A, Silva EC, Figueiredo MC, Turner MM, Durovni B, Lapa-E-Silva JR, Kritski AL, Cavalcante S, Rolla VC, Cordeiro-Santos M, Sterling TR, Andrade BB; RePORT Brazil consortium. The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts.J Infect Dis. 2021 May 19:jiab264. doi: 10.1093/infdis/jiab264. Epub ahead of print. PMID: 34008010
  31. Kulkarni V, Queiroz ATL, Sangle S, Kagal A, Salvi S, Gupta A, Ellner J, Kadam D, Rolla VC, Andrade BB, Salgame P, Mave V. A Two-Gene Signature for Tuberculosis Diagnosis in Persons With Advanced HIV. Front Immunol. 2021 Feb 22;12:631165. doi: 10.3389/fimmu.2021.631165. PMID: 33692804; PMCID: PMC7937880.
  32. Spener-Gomes R, Costa AG, Melo HF, Souza AB, Beraldi-Magalhães F, Jesus JS, Arriaga MB, Kritski A, Safe I, Andrade BB, Trajman A, Cordeiro-Santos M. Examination of respiratory specimens improves microbiological diagnosis of patients with presumptive extrapulmonary tuberculosis. IJID. 2021 Mar 12; doi: 10.1016/j.ijid.2021.03.022. PMID: 33722683.
  33. Peetluk LS, Ridolfi FM, Rebeiro PF, Liu D, Rolla VC, Sterling TR. Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults.BMJ Open. 2021 Mar 2;11(3):e044687. doi: 10.1136/bmjopen-2020-044687. PMID: 33653759; PMCID: PMC7929865.
  34. Barreto-Duarte B, Sterling TR, Fiske CT, Almeida A, Nochowicz CH, Smith RM, Barnett L, Warren C, Blackman A, Lapa E Silva JR, Andrade BB, Kalams SA. Increased Frequency of Memory CD4+ T-Cell Responses in Individuals With Previously Treated Extrapulmonary Tuberculosis. Front Immunol. 2020 Dec 17;11:605338. doi: 10.3389/fimmu.2020.605338. PMID: 33391271; PMCID: PMC7774017.
  35. Arriaga MB, Amorim G, Queiroz ATL, Rodrigues MMS, Araújo-Pereira M, Nogueira BMF, Souza AB, Rocha MS, Benjamin A, Moreira ASR, de Oliveira JG, Figueiredo MC, Turner MM, Alves K, Durovni B, Lapa-E-Silva JR, Kritski AL, Cavalcante S, Rolla VC, Cordeiro-Santos M, Sterling TR, Andrade BB; RePORT Brazil consortium. Novel stepwise approach to assess representativeness of a large multicenter observational cohort of tuberculosis patients: The example of RePORT Brazil. Int J Infect Dis. 2021 Feb;103:110-118. doi: 10.1016/j.ijid.2020.11.140. Epub 2020 Nov 14. PMID: 33197582; PMCID: PMC7959330.
  36. Silveira-Mattos PS, Barreto-Duarte B, Vasconcelos B, Fukutani KF, Vinhaes CL, Oliveira-De-Souza D, Ibegbu CC, Figueiredo MC, Sterling TR, Rengarajan J, Andrade BB. Differential Expression of Activation Markers by Mycobacterium tuberculosis-specific CD4+ T Cell Distinguishes Extrapulmonary From Pulmonary Tuberculosis and Latent Infection. Clin Infect Dis. 2020 Nov 5;71(8):1905-1911. doi: 10.1093/cid/ciz1070. PMID: 31665254.
  37. Demitto FO, Araújo-Pereira M, Schmaltz CA, Sant’Anna FM, Arriaga MB, Andrade BB, Rolla VC. Impact of Persistent Anemia on Systemic Inflammation and Tuberculosis Outcomes in Persons Living With HIV. Front Immunol. 2020 Sep 24;11:588405. doi: 10.3389/fimmu.2020.588405. PMID: 33072136; PMCID: PMC7541849.
  38. Rebeiro PF, Cohen MJ, Ewing HM, Figueiredo MC, Peetluk LS, Andrade KB, Eakin M, Zechmeister EJ, Sterling TR. Knowledge and stigma of latent tuberculosis infection in Brazil: implications for tuberculosis prevention strategies. BMC Public Health. 2020 Jun 9;20(1):897. doi: 10.1186/s12889-020-09053-1. PMID: 32517671; PMCID: PMC7285569.
  39. Penn-Nicholson A, Mbandi SK, Thompson E, Mendelsohn SC, Suliman S, Chegou NN, Malherbe ST, Darboe F, Erasmus M, Hanekom WA, Bilek N, Fisher M, Kaufmann SHE, Winter J, Murphy M, Wood R, Morrow C, Van Rhijn I, Moody B, Murray M, Andrade BB, Sterling TR, Sutherland J, Naidoo K, Padayatchi N, Walzl G, Hatherill M, Zak D, Scriba TJ; Adolescent Cohort Study team; GC6-74 Consortium; SATVI Clinical and Laboratory Team; ScreenTB Consortium; AE-TBC Consortium; RePORT Brazil Team; Peruvian Household Contacts Cohort Team; CAPRISA IMPRESS team. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. Sci Rep. 2020 May 25;10(1):8629. doi: 10.1038/s41598-020-65043-8. PMID: 32451443; PMCID: PMC7248089.
  40. Peetluk LS, Rebeiro PF, Cordeiro-Santos M, Kritski A, Andrade BB, Durovni B, Calvacante S, Arriaga MB, Turner MM, Figueiredo MC, Rolla VC, Sterling TR. Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis. J Infect Dis. 2020 Apr 7;221(9):1416-1424. doi: 10.1093/infdis/jiz595. PMID: 31724035; PMCID: PMC7137883.
  41. Cubillos-Angulo JM, Arriaga MB, Melo MGM, Silva EC, Alvarado-Arnez LE, de Almeida AS, Moraes MO, Moreira ASR, Lapa E Silva JR, Fukutani KF, Sterling TR, Hawn TR, Kritski AL, Oliveira MM, Andrade BB. Polymorphisms in interferon pathway genes and risk of Mycobacterium tuberculosis infection in contacts of tuberculosis cases in Brazil. Int J Infect Dis. 2020 Mar;92:21-28. doi: 10.1016/j.ijid.2019.12.013. Epub 2019 Dec 13. PMID: 31843671; PMCID: PMC7197195.
  42. Cubillos-Angulo JM, Arriaga MB, Silva EC, Müller BLA, Ramalho DMP, Fukutani KF, Miranda PFC, Moreira ASR, Ruffino-Netto A, Lapa E Silva JR, Sterling TR, Kritski AL, Oliveira MM, Andrade BB. Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study. Clin Infect Dis. 2019 Aug 30;69(6):1027-1035. doi: 10.1093/cid/ciy1001. PMID: 30481307; PMCID: PMC6735688
  43. van der Heijden YF, Abdullah F, Andrade BB, Andrews JR, Christopher DJ, Croda J, Ewing H, Haas DW, Hatherill M, Horsburgh CR Jr, Mave V, Nakaya HI, Rolla V, Srinivasan S, Sugiyono RI, Ugarte-Gil C, Hamilton C. Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting. Tuberculosis (Edinb). 2018 Dec;113:153-162. doi: 10.1016/j.tube.2018.09.009. Epub 2018 Oct 1. PMID: 30514497; PMCID: PMC6349374.
  44. Amaral EP, Conceição EL, Costa DL, Rocha MS, Marinho JM, Cordeiro-Santos M, D’Império-Lima MR, Barbosa T, Sher A, Andrade BB. N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions. BMC Microbiol. 2016 Oct 28;16(1):251. doi: 10.1186/s12866-016-0872-7. PMID: 27793104; PMCID: PMC5084440.
  45. Mesquita ED, Gil-Santana L, Ramalho D, Tonomura E, Silva EC, Oliveira MM, Andrade BB, Kritski A; Rede-TB Study group. Associations between systemic inflammation, mycobacterial loads in sputum and radiological improvement after treatment initiation in pulmonary TB patients from Brazil: a prospective cohort study. BMC Infect Dis. 2016 Aug 5;16:368. doi: 10.1186/s12879-016-1736-3. PMID: 27494953; PMCID: PMC4974760.
  46. Almeida-Junior JL, Gil-Santana L, Oliveira CA, Castro S, Cafezeiro AS, Daltro C, Netto EM, Kornfeld H, Andrade BB. Glucose Metabolism Disorder Is Associated with Pulmonary Tuberculosis in Individuals with Respiratory Symptoms from Brazil. PLoS One. 2016 Apr 14;11(4):e0153590. doi: 10.1371/journal.pone.0153590. PMID: 27078026; PMCID: PMC4831681.
  47. Gil-Santana L, Almeida-Junior JL, Oliveira CA, Hickson LS, Daltro C, Castro S, Kornfeld H, Netto EM, Andrade BB. Diabetes Is Associated with Worse Clinical Presentation in Tuberculosis Patients from Brazil: A Retrospective Cohort Study. PLoS One. 2016 Jan 11;11(1):e0146876. doi: 10.1371/journal.pone.0146876. PMID: 26752596; PMCID: PMC4709051.
  48. Miranda P, Gil-Santana L, Oliveira MG, Mesquita ED, Silva E, Rauwerdink A, Cobelens F, Oliveira MM, Andrade BB, Kritski A. Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation. PLoS One. 2017 Apr 6;12(4):e0175278. doi: 10.1371/journal.pone.0175278. PMID: 28384354; PMCID: PMC5383283.
  49. Geadas C, Stoszek SK, Sherman D, Andrade BB, Srinivasan S, Hamilton CD, Ellner J. Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international. Tuberculosis (Edinb). 2017 Jan;102:55-67. doi: 10.1016/j.tube.2016.11.006. Epub 2016 Nov 27. PMID: 28061953.
  50. Hamilton CD, Swaminathan S, Christopher DJ, Ellner J, Gupta A, Sterling TR, Rolla V, Srinivasan S, Karyana M, Siddiqui S, Stoszek SK, Kim P. RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration. Clin Infect Dis. 2015 Oct 15;61Suppl 3(Suppl 3):S155-9. doi: 10.1093/cid/civ611. PMID: 26409277; PMCID: PMC4583572.

Publications

  1. Sinha, P, Ezhumalai K, Du X, Ponnurjara C, Dauphinais MR, Gupte N, Sarkar S, Gupta A, Gaikwad S, Thankgakunam B, Paradkar M, Christopher DJ, Mave V, Visnwanathan V, Ellner JJ, Kornfield H, Horsburgh CR Jr, Padmapriyadarsini C, Gupte A. Undernourished Household Contacts are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection – a Multicenter Prospective Cohort Analysis. Clin Infect Dis. 2024 Apr 23: doi: 10.1093/cid/ciae149. PubMed PMID: 38652286
  2. Christopher DJ, Priya N, Shankar D, Isaac B, DeLuca A, Sarkar S, Prakash Babu S, Samuel P, Cattamanchi A, Gupta A, Ellner J, Srinivasan S, Cox S, Thangakunam B. Tuberculin test using Indian indigenous purified-protein derivative (PPD) shows only moderate agreement with international standard PPD. J Clin Tuberc Other Mycobact Dis. 2023 Dec 1;34:100404. doi: 10.1016/j.jctube.2023.100404. PMID: 38174327; PMCID: PMC10761766.
  3. Rocha EF, Vinhaes CL, Araujo-Pereira M, Mota TF, Gupta AN, Kumar NP, Arriage MB, Sterling TR, Babu S, Gaokwad S, Karyakarte R, Mave V, Kullkarni V, Parader M, Visnwanathan V, Kornfield H, Gupta A, Andrade BB, Quieroz ATL. The silent RNA in tuberculosis and the IncRNA role on Infection. 2024 Jan 19; 27(1): 108662.doi: 10.1016/j/isci. 20223. 108662. eCollection 2024 Jan 19. PMID: 38205253; PMCID PMC10777062
  4. Dixit A, Ektefaie Y, Kagal A, Freschi L, Karyakarte R, Lokhande R, Groschel M, Tornheim JA, Gupte N, Pradhan NN, Paradkar MS, Deshmukh S, Kadam D, Schito M, Engelthaler DM, Gupta A, Golub J, Mave V, Farhat M. Drug resistance and epidemiological success of modern Mycobacterium tuberculosis lineages in western India. J Infect Dis. 2024 May 31:jiae240. doi: 10.1093/infdis/jiae240. Epub ahead of print. PMID: 38819323.
  5. Pandiarajan AN, Kumar NP, Selvaraj N, Ahamed SF, Viswanathan V, Thiruvengadam K, Hissar S, Shanmugam S, Bethunaickan R, Nott S, Kornfeld H, Babu S. Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis. Front Immunol. 2024 Jun 3;15:1392256. doi: 10.3389/fimmu.2024.1392256. PMID: 38887283; PMCID: PMC11180841.
  6. Krishnan S, Gupte N, Paradkar M, Gupte A, Naik M, Raskar S, Suryavanshi N, Pradhan N, Gaikwad S, Karyakarte R, Lokhande R, Hanna Luke E, Thiruvengadam K, Chandrasekaran P, Sahasrabudhe T, Barthwal M, Kakrani A, Viswanathan V, Kornfeld H, Gupta A, Golub J, Mave V. Clinical and laboratory risk factors for pulmonary tuberculosis recurrence in three pooled Indian cohorts – Manuscript Published Frontiers in Tuberculosis, section Epidemiology of Tuberculosis. Frontiers. 2024 July 11. Volumen 2-Sec. Epidemiology of Tuberculosis. doi.org/10.3389/ftubr.2024.1433975
  7. Queiroz ATL, Vinhaes CL, Fukutani ER, Gupte AN, Kumar NP, Fukutani KF, Arriaga MB, Sterling TR, Babu S, Gaikwad S, Karyakarte R, Mave V, Paradkar M, Viswanathan V, Gupta A, Andrade BB, Kornfeld H. A multi-centre, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction. Sci Rep. 2023 May 12;13(1):7769. doi: 10.1038/s41598-023-34847-9. PMID: 37173394; PMCID: PMC10180618.
  8. Rocha EF, Vinhaes CL, Araújo-Pereira M, Mota TF, Gupte AN, Kumar NP, Arriaga MB, Sterling TR, Babu S, Gaikwad S, Karyakarte R, Mave V, Kulkarni V, Paradkar M, Viswanathan V, Kornfeld H, Gupta A, Andrade BB, Queiroz ATL.; The sound of silent RNA in tuberculosis and the lncRNA role on infection.RePORT Brazil; RePORT India Consortia. iScience. 2023 Dec 8;27(1):108662. doi: 10.1016/j.isci.2023.108662. PMID: 38205253; PMCID: PMC10777062.
  9. Sinha P, Ponnuraja C, Gupte N, Prakash Babu S, Cox SR, Sarkar S, Mave V, Paradkar M, Cintron C, Govindarajan S, Kinikar A, Priya N, Gaikwad S, Thangakunam B, Devarajan A, Dhanasekaran M, Tornheim JA, Gupta A, Salgame P, Christopher DJ, Kornfeld H, Viswanathan V, Ellner JJ, Horsburgh CR, Gupte AN, Padmapriyadarsini C, Hochberg NS. Impact of undernutrition on tuberculosis treatment outcomes in India: A multicenter, prospective, cohort analysis. Clin Infect Dis. 2023 Apr 17;76(8):1483-1491. doi: 10.1093/cid/ciac915. PMID: 36424864; PMCID: PMC10319769.
  10. Du X, Ponnuraja C, Gupte N, Sarkar S, Gupta A, Christopher DJ, Kornfeld H, Viswanathan V, Ellner J, Horsburgh CR Jr, Padmapriyadarsini C, Sinha P. Impact of baseline nutritional status on tuberculosis severity in India: A multicenter prospective cohort analysis. 1953 Open Forum Infect Dis. 2023 Nov 27;10(Suppl 2):ofad500.107. doi: 10.1093/ofid/ofad500.107. PMCID: PMC10677348.
  11. Christopher DJ, Priya N, Shankar D, Isaac B, DeLuca A, Sarkar S, Prakash Babu S, Samuel P, Cattamanchi A, Gupta A, Ellner J, Srinivasan S, Cox S, Thangakunam B. J Clin Tuberc Other Mycobact. Tuberculin test using Indian indigenous purified-protein derivative (PPD) shows only moderate agreement with international standard PPD Dis. 2023 Dec 1;34:100404. doi: 10.1016/j.jctube.2023.100404. PMID: 38174327; PMCID: PMC10761766.
  12. Cox SR, Padmapriyadarsini C, Mave V, Seth B, Thiruvengadam K, Gaikwad S, Sahasrabudhe TR, Sane M, Tornheim JA, Shrinivasa BM, Lokhande R, Barthwal MS, Shivakumar SVBY, Krishnan S, Santhappan R, Kinikar A, Kakrani AL, Paradkar M, Bollinger RC, Sekar K, Gupte AN, Hanna LE, Gupta A, Characterising cause of death among people treated for drug-susceptible TB in India Golub JE. Int J Tuberc Lung Dis. 2023 Jan 1;27(1):78-80. doi: 10.5588/ijtld.22.0454. PMID: 36853129.
  13. Hamada Y, Gupta RK, Quartagno M, Izzard A, Acuna-Villaorduna C, Altet N, Diel R, Dominguez J, Floyd S, Gupta A, Huerga H, Jones-López EC, Kinikar A, Lange C, van Leth F, Liu Q, Lu W, Lu P, Rueda IL, Martinez L, Mbandi SK, Muñoz L, Padilla ES, Paradkar M, Scriba T, Sester M, Shanaube K, Sharma SK, Sloot R, Sotgiu G, Thiruvengadam K, Vashishtha R, Abubakar I, Rangaka MX. Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis EClinicalMedicine. 2023 Jan 5;56:101815. doi: 10.1016/j.eclinm.2022.101815. PMID: 36636295; PMCID: PMC9829704.
  14. Deshmukh S, Sane M, Gaikwad S, Sahasrabudhe T, Barthwal M, Lokhande R, Raskar S, Kagal A, Dharmshale S, Pradhan N, Gupte A, Alfarisi O, Gupta A, Dooley KE, Gupte N, Sex differences in TB clinical presentation, drug exposure, and treatment outcomes in India Golub JE, Mave V. Chest. 2023 Apr;163(4):778-789. doi: 10.1016/j.chest.2022.09.024. Epub 2022 Sep 26. PMID: 36174745; PMCID: PMC10258435.
  15. Daniel EA, Thiruvengadam K, Rajamanickam A, Chandrasekaran P, Pattabiraman S, Bhanu B, Sivaprakasam A, Paradkar M, Kulkarni V, Karyakarte R, Shivakumar SVBY, Mave V, Gupta A, Babu S, QuantiFERON supernatant-based host biomarkers predicting progression to active tuberculosis disease among household contacts of tuberculosis patients Hanna LE. Clin Infect Dis. 2023 May 24;76(10):1802-1813. doi: 10.1093/cid/ciac979. PMID: 36582115.
  16. Jalbert E, Liu C, Mave V, Lang N, Kagal A, Valvi C, Paradkar M, Gupte N, Lokhande R, Bharadwaj R, Kulkarni V, Gupta A, Weinberg A. Comparative immune responses to Mycobacterium tuberculosis in people with latent infection or sterilizing protection iScience. 2023 Jul 20;26(8):107425. doi: 10.1016/j.isci.2023.107425. PMID: 37564701; PMCID: PMC10410524.
  17. Paradkar MS, Pradhan NN, Balaji S, Gaikwad SN, Chavan A, Dharmashale SN, Sahasrabudhe T, Lokhande R, Deshmukh SA, Barthwal M, Atre S, Raskar SS, Sawant TU, Gupte AN, Kakrani A, Golub J, Padmapriyadarsini C, Gupta A, Gupte NA, Mave V. Ann Am, Early microbiologic markers of pulmonary tuberculosis treatment outcomes Thorac Soc. 2023 Dec;20(12):1760-1768. doi: 10.1513/AnnalsATS.202302-144OC. PMID: 38038600; PMCID: PMC10704230.
  18. Ramachandran G, Hemanth Kumar AK, Kannan T, Thangakunam B, Shankar D, Christopher DJ., Pharmacokinetics of rifampicin, isoniazid & pyrazinamide during daily & intermittent dosing: A preliminary study Indian J Med Res. 2023 Feb-Mar;157(2&3):211-215. doi: 10.4103/ijmr.IJMR_1835_19. PMID: 36861539; PMCID: PMC10319390.
  19. Huddart S, Asege L, Jaganath D, Golla M, Dang H, Lovelina L, Derendinger B, Andama A, Christopher DJ, Nhung NV, Theron G, Denkinger CM, Nahid P, Cattamanchi A, Yu C., Continuous cough monitoring: a novel digital biomarker for TB diagnosis and treatment response monitoring Int J Tuberc Lung Dis. 2023 Mar 1;27(3):221-222. doi: 10.5588/ijtld.22.0511. PMID: 36855045; PMCID: PMC9983626.
  20. Kerkhoff AD, West NS, del Mar Castro M, Branigan D, Christopher DJ, Denkinger CM, Nhung NV, Theron G, Worodria W, Yu C, Muyoyeta M, Cattamanchi A., Placing the values and preferences of people most affected by TB at the center of screening and testing: an approach for reaching the unreached. BMC Global Public Health. 2023 Nov 21;1(27). https://doi.org/10.1186/s44263-023-00027-0
  21. Knudsen S, Babu SP, Ramakrishnan J, Jenkins HE, Joseph N, Cintron C, Narasimhan PB, Salgame P, Hochberg NS, Hom DL, Ellner J, Horsburgh CR, Sarkar S., tuberculosis infection before, during and after pregnancy Int J Tuberc Lung Dis. 2023 Jan 1;27(1):72-74. doi: 10.5588/ijtld.22.0390. PMID: 36853122.
  22. Carwile M, Cintron C, Jain K, Buonomo G, Oliver M, Dauphinais M, Narasimhan PB, Prakash Babu S, Sarkar S, Locks L, Kulatilaka N, Hochberg N, Lakshminarayanan S, Sinha P., Not business as usual: Engaging the corporate sector in India’s TB elimination efforts Glob Public Health. 2023 Jan;18(1):2120405. doi: 10.1080/17441692.2023.2216321. PMID: 37252903.
  23. Effect of treatment adherence on the association between sex and unfavourable treatment outcomes among tuberculosis patients in Puducherry, India: a mediation analysis Barathi A, Krishnamoorthy Y, Sinha P, Horsburgh C, Hochberg N, Johnson E, Salgame P, Govindarajan S, Senbagavalli PB, Lakshinarayanan S, Roy G, Ellner J, Sarkar S. J Public Health (Oxf). 2023 Jun 14;45(2):304-311. doi: 10.1093/pubmed/fdac062. PMID: 35692180; PMCID: PMC10273348.
  24. Lakshminarayanan S, Joseph NM, Soundappan G, Prakash Babu S, Horsburgh C, Hochberg N, Johnson WE, Knudsen S, Pentakota SR, Salgame P, Roy G, Ellner J., Development of prognostic scoring system for predicting 1-year mortality among pulmonary tuberculosis patients in South India J Public Health (Oxf). 2023 Jun 14;45(2):e184-e195. doi: 0.1093/pubmed/fdac087. PMID: 36038507; PMCID: PMC10273380.
  25. Kalva J, Babu SP, Narasimhan PB, Raghupathy K, Ezhumalai K, Knudsen S, Horsburgh CR, Hochberg N, Salgame P, Roy G, Ellner J, Sarkar S., Predictors of weight loss during the intensive phase of tuberculosis treatment in patients with drug-susceptible pulmonary tuberculosis in South India. J Public Health (Oxf). 2023 Aug 28;45(3):545-552. doi: 10.1093/pubmed/fdac141. PMID: 36451280; PMCID: PMC10470329.
  26. Kumar NP, Nancy A, Viswanathan V, Sivakumar S, Thiruvengadam K, Ahamed SF, Hissar S, Kornfeld H, Babu S., Chitinase and indoleamine 2, 3-dioxygenase are prognostic biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis Front Immunol. 2023 Feb 6;14:1093640. doi: 10.3389/fimmu.2023.1093640. PMID: 36814914; PMCID: PMC9939892.
  27. Kornfeld H, Procter-Gray E, Kumpatla S, Kane K, Li W, Magee MJ, Babu S, Viswanathan V. Longitudinal trends in glycated hemoglobin during and after tuberculosis treatment Diabetes Res Clin Pract. 2023 Feb;196:110242. doi: 10.1016/j.diabres.2023.110242. Epub 2023 Jan 7. PMID: 36627027.
  28. Viswanathan V, Devarajan A, Kumpatla S, Dhanasekaran M, Babu S, Kornfeld H. Effect of prediabetes on tuberculosis treatment outcomes: A study from South India Diabetes Metab Syndr. 2023 Jul;17(7):102801. doi: 10.1016/j.dsx.2023.102801. Epub 2023 Jun 8. PMID: 37354752; PMCID: PMC10528008.
  29. Resendiz-Galvan JE, Arora PR, Abdelwahab MT, Udwadia ZF, Rodrigues C, Gupta A, Denti P, Ashavaid TF, Tornheim JA. Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India Front Pharmacol. 2023 Jan 4;13:1081123. doi: 10.3389/fphar.2022.1081123. PMID: 36686664; PMCID: PMC9846493.
  30. Udwadia ZF, Patel JM, Batyala M, Tornheim JA, Rodrigues C. Title Swimming against the STREAM: Why STREAM 2 data cannot be easily applied to MDR-TB patients across India Lung India. 2023 May-Jun;40(3):290-291. doi: 10.4103/lungindia.lungindia_74_23. PMID: 37148033; PMCID: PMC10298808.

    Publications

    1. Burhan E, Karyana M, Karuniawati A, Kusmiati T, Wibisono BH, Handayani D, Riyanto BS, Sajinadiyasa IGK, Sinaga BYM, Djaharuddin I, Indah Sugiyono R, Susanto NH, Diana A, Kosasih H, Lokida D; Siswanto; Neal A, Lau CY, Siddiqui S. Characteristics of Drug-sensitive and Drug- resistant Tuberculosis Cases among Adults at Tuberculosis Referral Hospitals in Indonesia. Am J Trop Med Hyg. 2022 Oct 17;107(5):984-991. doi: 10.4269/ajtmh.22-0142. PMID: 36252800; PMCID: PMC9709011.

    2. Karuniawati A, Burhan E, Koendhori EB, Sari D, Haryanto B, Nuryastuti T, Gayatri AAAY, Bahrun U, Kusumawati RL, Sugiyono RI, Susanto NH, Diana A, Kosasih H, Naysilla AM, Lokida D, Neal A, Siddiqui S, Lau CY, Karyana M. Performance of Xpert MTB/RIF and sputum microscopy compared to sputum culture for diagnosis of tuberculosis in seven hospitals in Indonesia. Front Med (Lausanne). 2023 Jan 20;9:909198. doi: 10.3389/fmed.2022.909198. PMID: 36743681; PMCID: PMC9896521.

    3. Kusmiati T, Burhan E, Sugiyono RI, Arlinda D, Naysilla AM, Wibisono BH, El Khair R, Candrawati NW, Sinaga BY, Djaharrudin I, Lokida D. The seroprevalence of anti-Histoplasma capsulatum IgG antibody among pulmonary tuberculosis patients in seven referral tuberculosis hospitals in Indonesia. PLoS Neglected Tropical Diseases. 2023 Sep 20;17(9):e0011575.

    Publications

    1. Salgame P, Pentakota SR, Malabad JC, Narasimhan P, Verma S, Babu SP, et al. Diverse interactions of Mycobacterium tuberculosis infection and of BCG vaccination with SARS CoV-2. Frontiers in Tuberculosis 2024; 2:1-9 | https://doi.org/10.3389/ftubr.2024.1378068 
    2. Poblete J, Montoya J, Ang C, Rivera P, Kato S, Keicho N, Maeda S, Miyabayashi A, Lopez AL, Aldaba J, et al. Genetic diversity of Mycobacterium tuberculosis Isolates from a Rural Community in the Philippines. Phil Journal of Science 2021; 150(4): 669-78
    3. Lansang MAD, Alejandria MM, Law I, Juban NR, Amarillo MLE, Sison OT, et al. High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey. High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey. PLoS ONE 2021; 16(6): e0252240. https://doi.org/10.1371/journal.pone.0252240
    4. Lopez AL, Aldaba JG, Ama CG, Sylim PG, Geraldino XD, Sarol JN, Salonga AM. Surveillance for tuberculosis in a rural community in The Philippines. Int J Tuberc Lung Dis 2016; 20(11):1495–1500. http://dx.doi.org/10.5588/ijtld.16.0027 
    5. Alejandria, MM, Roa K, Serrano GK, Itable JR, Castillo-Carandang NT, Baja ES. Enhancing and maximizing participation of private health facilities in TB control. Policy Notes – Philippine Institute of Development Studies 2015; 29: 1-10
    6. Baja ES, Alejandria MM, Castillo-Carandang N, Itable JR, Serrano GK, Lansang MAD. Tuberculosis and diabetes mellitus control and care: The need for a coordinated response. Policy Notes – Philippine Institute of Development Studies 2015; 19: 1-8

      Publications

      1. Mulenga H, Musvosvi M, Mendelsohn SC, Penn-Nicholson A, Kimbung Mbandi S, Fiore-Gartland A, Tameris M, Mabwe S, Africa H, Bilek N, Kafaar F, Khader SA, Carstens B, Hadley K, Hikuam C, Erasmus M, Jaxa L, Raphela R, Nombida O, Kaskar M, Nicol MP, Mbhele S, Van Heerden J, Innes C, Brumskine W, Hiemstra A, Malherbe ST, Hassan-Moosa R, Walzl G, Naidoo K, Churchyard G, Hatherill M, Scriba TJ; CORTIS Study Team. Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis. Am J Respir Crit Care Med. 2021 Dec 15;204(12):1463-1472. doi: 10.1164/rccm.202103-0548OC.PMID: 34520313
      2. Penn-Nicholson A, Mbandi SK, Thompson E, Mendelsohn SC, Suliman S, Chegou NN, Malherbe ST, Darboe F, Erasmus M, Hanekom WA, Bilek N, Fisher M, Kaufmann SHE, Winter J, Murphy M, Wood R, Morrow C, Van Rhijn I, Moody B, Murray M, Andrade BB, Sterling TR, Sutherland J, Naidoo K, Padayatchi N, Walzl G, Hatherill M, Zak D, Scriba TJ; Adolescent Cohort Study team; GC6-74 Consortium; SATVI Clinical and Laboratory Team; ScreenTB Consortium; AE-TBC Consortium; RePORT Brazil Team; Peruvian Household Contacts Cohort Team; CAPRISA IMPRESS team. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. Sci Rep. 2020 May 25;10(1):8629. doi: 10.1038/s41598-020-65043-8. PMID: 32451443; PMCID: PMC7248089.
      3. Beltran CGG, Heunis T, Gallant J, Venter R, du Plessis N, Loxton AG, Trost M, Winter J, Malherbe ST, Kana BD, Walzl G. Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy. Front Cell Infect Microbiol. 2020 Aug 25;10:443. doi: 10.3389/fcimb.2020.00443. PMID: 32984071; PMCID: PMC7477326.
      4. Malherbe ST, Chen RY, Dupont P, Kant I, Kriel M, Loxton AG, Smith B, Beltran CGG, van Zyl S, McAnda S, Abrahams C, Maasdorp E, Doruyter A, Via LE, Barry CE 3rd, Alland D, Richards SG, Ellman A, Peppard T, Belisle J, Tromp G, Ronacher K, Warwick JM, Winter J, Walzl G. Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response. EJNMMI Res. 2020 Feb 10;10(1):8. doi: 10.1186/s13550-020-0591-9. PMID: 32040770; PMCID: PMC7010890.
      5. Chen RY, Via LE, Dodd LE, Walzl G, Malherbe ST, Loxton AG, Dawson R, Wilkinson RJ, Thienemann F, Tameris M, Hatherill M, Diacon AH, Liu X, Xing J, Jin X, Ma Z, Pan S, Zhang G, Gao Q, Jiang Q, Zhu H, Liang L, Duan H, Song T, Alland D, Tartakovsky M, Rosenthal A, Whalen C, Duvenhage M, Cai Y, Goldfeder LC, Arora K, Smith B, Winter J, Barry Iii CE; Predict TB Study Group. Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial. Gates Open Res. 2017 Nov 6;1:9. doi: 10.12688/gatesopenres.12750.1. PMID: 29528048; PMCID: PMC5841574.
      6. Lawal IO, Fourie BP, Mathebula M, Moagi I, Lengana T, Moeketsi N, Nchabeleng M, Hatherill M, Sathekge MM. 18F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary Tuberculosis. J Nucl Med. 2020 Mar;61(3):412-417. doi:10.2967/jnumed.119.233783. Epub 2019 Aug 26. PMID: 31451489.
      7. Osei Sekyere J, Reta MA, Maningi NE, Fourie PB. Antibiotic resistance of Mycobacterium tuberculosis complex in Africa: A systematic review of current reports of molecular epidemiology, mechanisms and diagnostics. J Infect. 2019 Dec;79(6):550-571. doi: 10.1016/j.jinf.2019.10.006. Epub 2019 Oct 16. PMID:31629017.
      8. Lawal IO, Fourie BP, Mathebula M, Moagi I, Lengana T, Moeketsi N, Nchabeleng M, Hatherill M, Sathekge MM. 18F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary Tuberculosis. J Nucl Med. 2020 Mar;61(3):412-417. doi: 10.2967/jnumed.119.233783. Epub 2019 Aug 26. PMID: 31451489.
      9. Ismaila, A., Lawal, I.O., Popoola, G.O. et al. [18F]FDG PET and CT findings at therapy completion of pulmonary tuberculosis: comparison between HIV-positive and HIV-negative patients and impact on treatment response assessment. Clin Transl Imaging(2024). https://doi.org/10.1007/s40336-024-00641-4
      10. Tavaziva G, Harris M, Abidi SK, Geric C, Breuninger M, Dheda K, Esmail A, Muyoyeta M, Reither K, Majidulla A, Khan AJ, Campbell JR, David PM, Denkinger C, Miller C, Nathavitharana R, Pai M, Benedetti A, Ahmad Khan F. Chest X-ray Analysis With Deep Learning-Based Software as a Triage Test for Pulmonary Tuberculosis: An Individual Patient Data Meta-Analysis of Diagnostic Accuracy. Clin Infect Dis. 2022 Apr 28;74(8):1390-1400. doi: 10.1093/cid/ciab639. PMID: 34286831; PMCID: PMC9049274.
      11. Theron G, Limberis J, Venter R, Smith L, Pietersen E, Esmail A, Calligaro G, Te Riele J, de Kock M, van Helden P, Gumbo T, Clark TG, Fennelly K, Warren R, Dheda K. Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis. Nat Med. 2020 Sep;26(9):1435-1443. doi: 10.1038/s41591-020-0940-2. Epub 2020 Jun 29. PMID: 32601338; PMCID: PMC8353872
      12. Esmail A, Tomasicchio M, Meldau R, Makambwa E, Dheda K. Comparison of Xpert MTB/RIF (G4) and Xpert Ultra, including trace readouts, for the diagnosis of pulmonary tuberculosis in a TB and HIV endemic setting. Int J Infect Dis. 2020 Jun;95:246-252. doi: 10.1016/j.ijid.2020.03.025. Epub 2020 Apr 2. PMID: 32247825.
      13. Moyo M, Lebina L, Milovanovic M, MacPherson P, Michel A, Martinson N. Tuberculosis patients at the human-animal interface: Potential zooanthroponotic and zoonotic transmission. One Health. 2021 Aug 30;13:100319. doi: 10.1016/j.onehlt.2021.100319. PMID: 34504938; PMCID: PMC8417387
      14. Ndlovu LN, Peetluk L, Moodley S, Nhamoyebonde S, Ngoepe AT, Mazibuko M, Khan K, Karim F, Pym AS, Maruri F, Moosa MS, van der Heijden YF, Sterling TR, Leslie A. Increased Neutrophil Count and Decreased Neutrophil CD15 Expression Correlate With TB Disease Severity and Treatment Response Irrespective of HIV Co-infection. Front Immunol. 2020 Aug 28;11:1872. doi: 10.3389/fimmu.2020.01872. PMID: 32983107; PMCID: PMC7485225.
      15. Walker NF, Karim F, Moosa M, Moodley S, Mazibuko M, Khan K, Sterling TR, van der Heijden YF, Grant AD, Elkington PT, Pym A, Leslie A. Elevated plasma matrix metalloproteinase-8 associates with sputum culture positivity in pulmonary tuberculosis. J Infect Dis. In press
      16. Arriaga MB, Karim F, Queiroz ATL, Araújo-Pereira M, Barreto-Duarte B, Sales C, Moosa MYS, Mazibuko M, Milne GL, Maruri F, Serezani CH, Koethe JR, Figueiredo MC, Kritski AL, Cordeiro-Santos M, Rolla VC, Sterling TR, Leslie A, Andrade BB, for RePORT-Brazil & South Africa consortia. Effect of dysglycemia on urinary lipid mediator profiles in persons with pulmonary TB. Front Immunol. In press.
      17. Cox H, Workman L, Bateman L, Franckling-Smith Z, Prins M, Luiz J, Van Heerden J, Edries LAT, Africa S, Allen V, Baard C, Zemanay W, Nicol MP, Zar HJ. Oral swabs tested with Xpert MTB/RIF Ultra for diagnosis of pulmonary tuberculosis in children: a diagnostic accuracy study. Clin Infect Dis. 2022 May 17:ciac332. doi: 10.1093/cid/ciac332. Epub ahead of print. PMID: 35579497.
      18. Copelyn J, Eley B, Cox H, Workman L, Dheda K, Nicol MP, Zar HJ. Treatment Response in Pediatric Pulmonary Tuberculosis-A Prospective Longitudinal Study. J Pediatric Infect Dis Soc. 2022 Apr 24:piac029. doi: 10.1093/jpids/piac029. Epub ahead of print. PMID: 35462407.
      19. Nel M, Franckling-Smith Z, Pillay T, Andronikou S, Zar HJ. Chest Imaging for Pulmonary TB – An Update. Pathogens. 2022;11:161. doi:10.3390/pathogens11020161.
      20. Nicol MP, Schumacher SG, Workman L, Broger T, Baard C, Prins M, Bateman L, du Toit E, van Heerden J, Szekely R, Zar HJ, Denkinger CM. Accuracy of a Novel Urine Test, Fujifilm SILVAMP Tuberculosis Lipoarabinomannan, for the Diagnosis of Pulmonary Tuberculosis in Children. Clin Infect Dis. 2021 May 4;72(9):e280-e288. doi: 10.1093/cid/ciaa1052. PMID: 32761178; PMCID: PMC8096212.
      21. Bobak CA, Kang L, Workman L, Bateman L, Khan MS, Prins M, May L, Franchina FA, Baard CB, Nicol M, Zar H, Hill JE. Breath can discriminate tuberculosis from other lower respiratory illness in children. Sci Rep. 2021;11:2704. doi:10.1038/s41598-021-80970-w.
      22. DeAtley T, Workman L, Theron G, Bélard S, Prins M, Bateman L, Grobusch MP, Dheda K, Nicol MP, Sorsdahl K, Kuo C, Stein DJ, Zar HJ. The child ecosystem and childhood pulmonary tuberculosis: A South African perspective. Pediatric Pulmonol. 2021 Feb;56:2212-2222. doi:10.1002/ppul.25369.
      23. Marais BJ, Nicol M, Zar HJ. Key advances and remaining challenges in childhood and adolescent tuberculosis. Paediatr Respir Rev. 2020 Nov;36:25-26. doi: 10.1016/j.prrv.2020.07.008. Epub 2020 Aug 1. PMID: 32830068.
      24. Nicol MP, Zar HJ. Advances in the diagnosis of pulmonary tuberculosis in children. Paediatr Respir Rev. 2020 Nov;36:52-56. doi:10.1016/j.prrv.2020.05.003. Epub 2020 May 25. PMID: 32624357; PMCID: PMC7686111.
      25. Pillay T, Andornikou S, Zar HJ. Chest imaging in paediatric pulmonary TB. Paediatric Respir Rev. 2020;36:65-72. doi:10.1016/j.prrv.2020.10.002.
      26. Zar HJ, Workman LJ, Prins M, Bateman LJ, Mbhele SP, Whitman CB, Denkinger CM, Nicol MP. Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens. Am J Respir Crit Care Med. 2019 Dec 15;200(12):1531-1538. doi: 10.1164/rccm.201904-0772OC. PMID: 31381861; PMCID: PMC6909828.
      27. Nicol MP, Wood RC, Workman L, Prins M, Whitman C, Ghebrekristos Y, Mbhele S, Olson A, Jones-Engel LE, Zar HJ, Cangelosi GA. Microbiological diagnosis of pulmonary tuberculosis in children by oral swab polymerase chain reaction. Sci Rep. 2019 Jul 25;9(1):10789. doi: 10.1038/s41598-019-47302-5. PMID: 31346252;PMCID: PMC6658562.
      28. Nicol MP, Workman L, Prins M, Bateman L, Ghebrekristos Y, Mbhele S, Denkinger CM, Zar HJ. Accuracy of Xpert Mtb/Rif Ultra for the Diagnosis of Pulmonary Tuberculosis in Children. Pediatr Infect Dis J. 2018 Oct;37(10):e261-e263. doi: 10.1097/INF.0000000000001960. PMID: 29474257.
      29. Elsingergy MM, Naidoo J, Baker G, Zar HJ, Lucas S, Andronikou S. Comparison of chest radiograph findings in ambulatory and hospitalized children with pulmonary tuberculosis. Pediatr Radiol. 2023 Jul 10. doi: 10.1007/s00247-023-05707-5. Epub ahead of print. PMID: 37423915.
      30. Gunasekera KS, Marcy O, Muñoz J, Lopez-Varela E, Sekadde MP, Franke MF, Bonnet M, Ahmed S, Amanullah F, Anwar A, Augusto O, Aurilio RB, Banu S, Batool I, Brands A, Cain KP, Carratalá-Castro L, Caws M, Click ES, Cranmer LM, García-Basteiro AL, Hesseling AC, Huynh J, Kabir S, Lecca L, Mandalakas A, Mavhunga F, Myint AA, Myo K, Nampijja D, Nicol MP, Orikiriza P, Palmer M, Sant’Anna CC,Siddiqui SA, Smith JP, Song R, Thuong Thuong NT, Ung V, van der Zalm MM, Verkuijl S, Viney K, Walters EG, Warren JL, Zar HJ, Marais BJ, Graham SM, Debray TPA, Cohen T, Seddon JA. Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis. Lancet Child Adolesc Health. 2023 Mar 13:S2352-4642(23)00004-4. doi: 10.1016/S2352-4642(23)00004-4. Epub ahead of print. PMID: 36924781.
      31. Pillay T, Zar HJ, Venkatakrishna SSB, Andronikou S. Fast magnetic resonance imaging for diagnosing pulmonary tuberculosis in children: the sub-10-min unenhanced scan. Pediatric Radiology. http://dx.doi.org/10.1007/s00247-023-05683-w
      32. van der Heijden YF, Abdullah F, Andrade BB, Andrews JR, Christopher DJ, Croda J, Ewing H, Haas DW, Hatherill M, Horsburgh CR Jr, Mave V, Nakaya HI, Rolla V, Srinivasan S, Sugiyono RI, Ugarte-Gil C, Hamilton C. Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting. Tuberculosis (Edinb). 2018 Dec;113:153-162. doi: 10.1016/j.tube.2018.09.009.